Skip to main content
Proinflammatory cytokine evaluation from human PBMCs in response to AAV8 peptides
Application Note

Proinflammatory cytokine evaluation from human PBMCs in response to AAV8 peptides

Discover groundbreaking insights into immune responses to AAV with our latest application note, "Proinflammatory Cytokine Evaluation from Human PBMCs in Response to AAV8 Peptides." This study unveils critical data on how individual immune systems react to AAV-based gene therapy vectors, . Explore the advanced methodologies employed, such as the HTRF and ELISpot assays, which provide a deeper understanding of cytokine profiles post-treatment. This application note is a vital resource for researchers and healthcare professionals aiming to enhance gene therapy strategies. Dive into the full document to equip yourself with the latest knowledge in immunogenicity assessment.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

Proinflammatory cytokine evaluation from human PBMCs in response to AAV8 peptides